ALKBH1 promotes lung cancer by regulating m6A RNA demethylation

Hong Li,Ying Zhang,Yajuan Guo,Rong Liu,Qi Yu,Lingzhi Gong,Zhongqiu Liu,Wei Xie,Caiyan Wang

DOI: https://doi.org/10.1016/j.bcp.2020.114284

IF: 6.1

2021-07-01

Biochemical Pharmacology

Abstract:<p>Lung cancer has surpassed breast cancer as the leading cause of cancer death in females in developed countries and the leading cause of cancer death in males. Despite extensive research on lung cancer, the pathogenesis of lung cancer is not fully understood. ALKBH1 is a 2-oxoglutarate and Fe (II)-dependent dioxygenase responsible for the demethylation of 6-methyladenine (m6A) in RNA and is essential to multiple cellular processes in human. Numerous recent studies suggested that ALKBH1 played a role in tumorigenesis and tumor progression, but the role of ALKBH1 in lung cancer is largely unknown. In this study, we demonstrated that the expression levels of ALKBH1 in lung cancer tissues and cells were up regulated. The invasion and migration abilities of lung cancer cells were significantly suppressed <em>in vitro</em> upon the silencing of ALKBH1 while they were significantly promoted upon its overexpression. We next characterized the enzyme biochemically by analyzing the contribution of essential residues Y184, H231, D233, H287, R338, and R344 to its m6A demethylation activity. Lastly, our 3.1-Å crystal structure of mouse ALKBH1 revealed that the N-terminal domain of the protein forms close contacts with the core catalytic domain and might be responsible for the recognition of nucleic acid substrates. In summary, our combined cellular, biochemical, and structural results provide insight into the potential ALKBH1-based drug design for cancer therapies.</p>

pharmacology & pharmacy

What problem does this paper attempt to address?

This paper aims to explore the mechanism of action of ALKBH1 in the occurrence and development of lung cancer. Specifically, the researchers found that ALKBH1 promotes the development of lung cancer by regulating m6A demethylation on RNA. ALKBH1 is a 2 - oxoglutarate - and Fe(II) - dependent dioxygenase responsible for the demethylation process of 6 - methyladenine (m6A) on RNA, and this process is crucial for multiple cellular functions. Although previous studies have shown that ALKBH1 plays a role in the occurrence and development of tumors, its specific role in lung cancer remains unclear. To verify the role of ALKBH1 in lung cancer, the researchers first detected the expression level of ALKBH1 in lung cancer tissues and cells and found that it was significantly up - regulated. Further in - vitro experiments showed that inhibiting the expression of ALKBH1 could significantly reduce the invasion and migration abilities of lung cancer cells, while over - expressing ALKBH1 would enhance these abilities. In addition, the researchers also analyzed the contribution of the key residues of ALKBH1 to its m6A demethylation activity by biochemical methods and resolved the 3.1 - Å crystal structure of mouse ALKBH1, revealing the close contact between the N - terminal domain and the core catalytic domain, which may be related to its ability to recognize nucleic acid substrates. In summary, this study not only clarifies the role of ALKBH1 in the development of lung cancer and its molecular mechanism, but also provides a theoretical basis for the design of anti - cancer drugs based on ALKBH1.

ALKBH1 promotes lung cancer by regulating m6A RNA demethylation

Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer

RNA Demethylase ALKBH5 in Cancer: from Mechanisms to Therapeutic Potential.

ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages

m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC

RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

The biological function of m6A demethylase ALKBH5 and its role in human disease

ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1

ALKBH5 Functions As an Oncogene in Multiple Myeloma

The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma

ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer

RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia.

ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner

m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling

RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner

N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression

RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways

M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications

ALKBH5 promotes the development of lung adenocarcinoma by regulating the polarization of M2 macrophages through CDCA4

The role of the ALKBH5 RNA demethylase in invasive breast cancer